10 Least Obese Countries in the World
The 10 least obese countries in the world are mostly from Asia and Africa.
Merck Sharp & Dohme Corp. (MRK)
Market is closed
News
- First
- << Previous
- 571 - 580
- Next >>
Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug
Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc.
Are Hedge Funds Turning Bearish on Healthcare Stocks?
Healthcare stocks generally offer good dividend yields and a safe stream of cash flow given the recession-proof nature of the industry.
FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE).
Merck & Co., Inc. (MRK) In $2.9 Billion Writedown After Market For Hepatitis C Drug Market Shrinks
Merck & Co., Inc. (NYSE:MRK) has announced that it will be writing down approximately $2.9 billion following the shrinking of the market for a hepatitis drug it owns.
Why President Trump Wants To Transform The FDA - And What It Could Mean For Biotech Stocks
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at a level no one has ever...
Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK), And Other Pharmaceutical Firms All Targeting I-O Segment
Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years. Pharmaceutical firms such as Bristol-Myers Squibb Co (NYSE:BMY) and Merck & Co., Inc.
The FDA Accepts Keytruda From Merck & Co., Inc. (MRK) For Bladder Cancer
Patients with bladder cancer now having something to smile about, after the acceptance of 2 new supplemental biologics license applications, by the FDA.
The European Medicines Agency (EMA) Recommends KEYTRUDA From Merck & Co., Inc. (MRK)
The European Commission has approved KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy from Merck & Co., Inc. (NYSE:MRK).
Pharmaceutical Executives From Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ) Met Trump
United States President Donald Trump is urging US drugmakers to consider manufacturing more of their drugs in the United States, thinking that higher cost manufacturing at the expense of profits would...
- First
- << Previous
- 571 - 580
- Next >>
Billionaire Hedge Funds
